Acoramidis - BridgeBio Pharma
At a glance
- Drug Originator Stanford University
- Drug Licenced by Alexion AstraZeneca Rare Disease; Bayer; BridgeBio Pharma
- Drug Class Benzoic acids; Ethers; Fluorobenzenes; Pyrazoles; Small molecules
- Mechanism of Action Prealbumin modulators
- USA Patent Applicants BRIDGEBIO PHARMA
- USA Patents 17
- NDAs 1
- International Patents 82
- Patent Applications 31

Disclaimer